Anticoagulant Drugs [phsu]
Prevention [topp]
Restenosis [acab]
Reocclusion [inpo]
Following [tmco]
Peripheral [spco]
endovascular [blor]
treatment [ftcn]
peripheral arterial disease [dsyn]
Frequently [tmco]
treated [topp]
Angioplasty, Balloon [topp]
Restenosis [acab]
Reocclusion [inpo]
Dilated segment [patf]
Often [tmco]
depend [medd]
Length [qnco]
Occlusion [ortf]
Lower leg [blor]
Stage [tmco]
cardiovascular risk factor [dsyn]
PREVENT [phsu]
Reocclusion [inpo]
Patients [podg]
treated [topp]
Antithrombotic Agents [phsu]
Update [tmco]
Published [ocac]
objectives [inpr]
Drug [phsu]
effective [qlco]
PREVENT [phsu]
Restenosis [acab]
Reocclusion [inpo]
Peripheral [spco]
endovascular [blor]
treatment [ftcn]
Compared [acty]
Drug [phsu]
treatment [ftcn]
placebo [topp]
Vasoactive [qlco]
Drug [phsu]
search [inpr]
Methods [inpr]
Update [tmco]
Peripheral Vascular Diseases [dsyn]
Group [idcn]
Trial [resa]
search [inpr]
Searched [acty]
specialised [qlco]
Last [qlco]
Searched [acty]
Central [spco]
Issue [fndg]
Selection Criteria [qlco]
Select [acty]
Controlled [ftcn]
Trial [resa]
participants [popg]
Patients [podg]
Symptomatic [ftcn]
peripheral arterial disease [dsyn]
treated [topp]
endovascular [blor]
Revascularisation [topp]
Pelvic [blor]
femoro-popliteal [bpoc]
Arteries [bpoc]
interventions [hlca]
Anticoagulant [phsu]
Vasoactive [qlco]
Drug Therapy [topp]
Compared [acty]
treatment [ftcn]
placebo [topp]
Vasoactive [qlco]
Drug [phsu]
Clinical Endpoint [clna]
Reocclusion [inpo]
Restenosis [acab]
Amputation [topp]
Myocardial Infarction [dsyn]
Stroke [dsyn]
Bleeding [patf]
side effects [ftcn]
Minor [popg]
Bleeding [patf]
Puncture [fndg]
Site [spco]
Bleeding [patf]
gastrointestinal [spco]
side effects [ftcn]
Haematoma [patf]
Data Collection [resa]
Extracted [topp]
Assessed [acty]
Details [qlco]
Patients [podg]
treatment [ftcn]
Study Design [resa]
Characteristics [qlco]
Bias [idcn]
Based [ftcn]
Intention [menp]
effects [qlco]
Reocclusion [inpo]
Restenosis [acab]
Amputation [topp]
Bleeding [patf]
Computed [lbpr]
Odds Ratios [qnco]
Confidence Intervals [qnco]
Fixed [fndg]
Main [qlco]
twenty [orch, phsu]
Trial [resa]
Patients [podg]
included [ftcn]
Original [idcn]
Eight [qnco]
Update [tmco]
majority [socb]
Comparison [acty]
Trial [resa]
Available [ftcn]
Rarely [qlco]
Combined [qlco]
meta-analyses [resa]
Trial [resa]
Small [qnco]
Bias [idcn]
Often [tmco]
limitations [ftcn]
Reporting [hlca]
Trial [resa]
Reported [inpr]
Drug [phsu]
Placebo Control [resa]
Available [ftcn]
Maximum [qnco]
Six [qnco]
months [tmco]
Six [qnco]
months [tmco]
Post-intervention [inpr]
statistically significant [qnco]
reduction [npop]
Reocclusion [inpo]
High dose [qnco]
Acetylsalicylic Acid [orch, phsu]
Combined [qlco]
Dipyridamole [orch, phsu]
Odds Ratios [qnco]
Confidence Intervals [qnco]
Low dose [qnco]
Acetylsalicylic Acid [orch, phsu]
Combined [qlco]
Dipyridamole [orch, phsu]
Odds Ratios [qnco]
Confidence Intervals [qnco]
P NOS [aapp, imft]
Amputations [topp]
LIPO [neop]
Ecraprost [eico, phsu]
Odds Ratios [qnco]
Confidence Intervals [qnco]
Remaining [qlco]
Trial [resa]
Compared [acty]
Drugs [phsu]
Available [ftcn]
Long [qlco]
months [tmco]
months [tmco]
Post-intervention [inpr]
statistically significant [qnco]
Reocclusion [inpo]
Restenosis [acab]
Detected [fndg]
Following [tmco]
Comparison [acty]
High dose [qnco]
Acetylsalicylic Acid [orch, phsu]
Low dose [qnco]
Acetylsalicylic Acid [orch, phsu]
Odds Ratios [qnco]
Confidence Intervals [qnco]
P NOS [aapp, imft]
Acetylsalicylic Acid [orch, phsu]
Dipyridamole [orch, phsu]
Vitamin K antagonists [phsu]
Odds Ratios [qnco]
Confidence Intervals [qnco]
P NOS [aapp, imft]
clopidogrel [orch, phsu]
Aspirin [orch, phsu]
Heparin, Low-Molecular-Weight [carb, phsu]
Plus [qlco]
Warfarin [hops, orch, phsu]
Odds Ratios [qnco]
Confidence Intervals [qnco]
P NOS [aapp, imft]
Suloctidil [orch, phsu]
Vitamin K antagonists [phsu]
Reocclusion [inpo]
Odds Ratios [qnco]
Confidence Intervals [qnco]
P NOS [aapp, imft]
Restenosis [acab]
Odds Ratios [qnco]
Confidence Intervals [qnco]
P NOS [aapp, imft]
Ticlopidine [orch, phsu]
Vitamin K antagonists [phsu]
Odds Ratios [qnco]
Confidence Intervals [qnco]
P NOS [aapp, imft]
treatment [ftcn]
cilostazol [orch, phsu]
Statistically [ocdi]
Reocclusion [inpo]
Ticlopidine [orch, phsu]
Odds Ratios [qnco]
Confidence Intervals [qnco]
P NOS [aapp, imft]
Compared [acty]
Aspirin [orch, phsu]
Alone [qnco]
Heparin, Low-Molecular-Weight [carb, phsu]
Plus [qlco]
Decreased [qnco]
Occlusion [ortf]
Restenosis [acab]
Patients [podg]
critical limb ischaemia [patf]
Odds Ratios [qnco]
Confidence Intervals [qnco]
P NOS [aapp, imft]
Patients [podg]
Intermittent Claudication [dsyn]
Odds Ratios [qnco]
Confidence Intervals [qnco]
P NOS [aapp, imft]
Batroxobin [aapp, enzy, hops]
Plus [qlco]
Aspirin [orch, phsu]
Reduced [qlco]
Restenosis [acab]
diabetic [fndg]
Patients [podg]
Odds Ratios [qnco]
Confidence Intervals [qnco]
Bleeding [patf]
gastrointestinal [spco]
side effects [ftcn]
Reported [inpr]
High dose [qnco]
Acetylsalicylic Acid [orch, phsu]
Increased [qnco]
gastrointestinal [spco]
side effects [ftcn]
Compared [acty]
Low dose [qnco]
Acetylsalicylic Acid [orch, phsu]
clopidogrel [orch, phsu]
Aspirin [orch, phsu]
Few [qnco]
Bleeding episodes [fndg]
Compared [acty]
Heparin, Low-Molecular-Weight [carb, phsu]
Plus [qlco]
Warfarin [hops, orch, phsu]
abciximab [aapp, imft, phsu]
Severe [qlco]
Bleeding episodes [fndg]
Authors [prog]
Conclusions [idcn]
Limited [ftcn]
Suggest [idcn]
Restenosis [acab]
Reocclusion [inpo]
Six [qnco]
months [tmco]
Following [tmco]
Peripheral [spco]
endovascular [blor]
treatment [ftcn]
Reduced [qlco]
Antiplatelet Drugs [phsu]
Compared [acty]
Placebo Control [resa]
Information [idcn]
Bleeding [patf]
gastrointestinal [spco]
side effects [ftcn]
Lacking [qlco]
Variation [qlco]
Drugs [phsu]
cilostazol [orch, phsu]
Reducing [qlco]
Reocclusion [inpo]
Restenosis [acab]
months [tmco]
Compared [acty]
Ticlopidine [orch, phsu]
Heparin, Low-Molecular-Weight [carb, phsu]
Batroxobin [aapp, enzy, hops]
Combined [qlco]
Aspirin [orch, phsu]
APPEAR [qlco]
Compared [acty]
Aspirin [orch, phsu]
Alone [qnco]
Available [ftcn]
Trial [resa]
Small [qnco]
Variable [qlco]
Quality [qlco]
side effects [ftcn]
Drugs [phsu]
Address [inpr]
Good [qlco]
Quality [qlco]
Large [qnco]
Scale [medd]
Controlled [ftcn]
Trial [resa]
Stratified [qlco]
Severity [qlco]
Required [ftcn]
